Tag Archives: interest

#432691 Is the Secret to Significantly Longer ...

Once upon a time, a powerful Sumerian king named Gilgamesh went on a quest, as such characters often do in these stories of myth and legend. Gilgamesh had witnessed the death of his best friend, Enkidu, and, fearing a similar fate, went in search of immortality. The great king failed to find the secret of eternal life but took solace that his deeds would live well beyond his mortal years.

Fast-forward four thousand years, give or take a century, and Gilgamesh (as famous as any B-list celebrity today, despite the passage of time) would probably be heartened to learn that many others have taken up his search for longevity. Today, though, instead of battling epic monsters and the machinations of fickle gods, those seeking to enhance and extend life are cutting-edge scientists and visionary entrepreneurs who are helping unlock the secrets of human biology.

Chief among them is Aubrey de Grey, a biomedical gerontologist who founded the SENS Research Foundation, a Silicon Valley-based research organization that seeks to advance the application of regenerative medicine to age-related diseases. SENS stands for Strategies for Engineered Negligible Senescence, a term coined by de Grey to describe a broad array (seven, to be precise) of medical interventions that attempt to repair or prevent different types of molecular and cellular damage that eventually lead to age-related diseases like cancer and Alzheimer’s.

Many of the strategies focus on senescent cells, which accumulate in tissues and organs as people age. Not quite dead, senescent cells stop dividing but are still metabolically active, spewing out all sorts of proteins and other molecules that can cause inflammation and other problems. In a young body, that’s usually not a problem (and probably part of general biological maintenance), as a healthy immune system can go to work to put out most fires.

However, as we age, senescent cells continue to accumulate, and at some point the immune system retires from fire watch. Welcome to old age.

Of Mice and Men
Researchers like de Grey believe that treating the cellular underpinnings of aging could not only prevent disease but significantly extend human lifespans. How long? Well, if you’re talking to de Grey, Biblical proportions—on the order of centuries.

De Grey says that science has made great strides toward that end in the last 15 years, such as the ability to copy mitochondrial DNA to the nucleus. Mitochondria serve as the power plant of the cell but are highly susceptible to mutations that lead to cellular degeneration. Copying the mitochondrial DNA into the nucleus would help protect it from damage.

Another achievement occurred about six years ago when scientists first figured out how to kill senescent cells. That discovery led to a spate of new experiments in mice indicating that removing these ticking-time-bomb cells prevented disease and even extended their lifespans. Now the anti-aging therapy is about to be tested in humans.

“As for the next few years, I think the stream of advances is likely to become a flood—once the first steps are made, things get progressively easier and faster,” de Grey tells Singularity Hub. “I think there’s a good chance that we will achieve really dramatic rejuvenation of mice within only six to eight years: maybe taking middle-aged mice and doubling their remaining lifespan, which is an order of magnitude more than can be done today.”

Not Horsing Around
Richard G.A. Faragher, a professor of biogerontology at the University of Brighton in the United Kingdom, recently made discoveries in the lab regarding the rejuvenation of senescent cells with chemical compounds found in foods like chocolate and red wine. He hopes to apply his findings to an animal model in the future—in this case,horses.

“We have been very fortunate in receiving some funding from an animal welfare charity to look at potential treatments for older horses,” he explains to Singularity Hub in an email. “I think this is a great idea. Many aspects of the physiology we are studying are common between horses and humans.”

What Faragher and his colleagues demonstrated in a paper published in BMC Cell Biology last year was that resveralogues, chemicals based on resveratrol, were able to reactivate a protein called a splicing factor that is involved in gene regulation. Within hours, the chemicals caused the cells to rejuvenate and start dividing like younger cells.

“If treatments work in our old pony systems, then I am sure they could be translated into clinical trials in humans,” Faragher says. “How long is purely a matter of money. Given suitable funding, I would hope to see a trial within five years.”

Show Them the Money
Faragher argues that the recent breakthroughs aren’t because a result of emerging technologies like artificial intelligence or the gene-editing tool CRISPR, but a paradigm shift in how scientists understand the underpinnings of cellular aging. Solving the “aging problem” isn’t a question of technology but of money, he says.

“Frankly, when AI and CRISPR have removed cystic fibrosis, Duchenne muscular dystrophy or Gaucher syndrome, I’ll be much more willing to hear tales of amazing progress. Go fix a single, highly penetrant genetic disease in the population using this flashy stuff and then we’ll talk,” he says. “My faith resides in the most potent technological development of all: money.”

De Grey is less flippant about the role that technology will play in the quest to defeat aging. AI, CRISPR, protein engineering, advances in stem cell therapies, and immune system engineering—all will have a part.

“There is not really anything distinctive about the ways in which these technologies will contribute,” he says. “What’s distinctive is that we will need all of these technologies, because there are so many different types of damage to repair and they each require different tricks.”

It’s in the Blood
A startup in the San Francisco Bay Area believes machines can play a big role in discovering the right combination of factors that lead to longer and healthier lives—and then develop drugs that exploit those findings.

BioAge Labs raised nearly $11 million last year for its machine learning platform that crunches big data sets to find blood factors, such as proteins or metabolites, that are tied to a person’s underlying biological age. The startup claims that these factors can predict how long a person will live.

“Our interest in this comes out of research into parabiosis, where joining the circulatory systems of old and young mice—so that they share the same blood—has been demonstrated to make old mice healthier and more robust,” Dr. Eric Morgen, chief medical officer at BioAge, tells Singularity Hub.

Based on that idea, he explains, it should be possible to alter those good or bad factors to produce a rejuvenating effect.

“Our main focus at BioAge is to identify these types of factors in our human cohort data, characterize the important molecular pathways they are involved in, and then drug those pathways,” he says. “This is a really hard problem, and we use machine learning to mine these complex datasets to determine which individual factors and molecular pathways best reflect biological age.”

Saving for the Future
Of course, there’s no telling when any of these anti-aging therapies will come to market. That’s why Forever Labs, a biotechnology startup out of Ann Arbor, Michigan, wants your stem cells now. The company offers a service to cryogenically freeze stem cells taken from bone marrow.

The theory behind the procedure, according to Forever Labs CEO Steven Clausnitzer, is based on research showing that stem cells may be a key component for repairing cellular damage. That’s because stem cells can develop into many different cell types and can divide endlessly to replenish other cells. Clausnitzer notes that there are upwards of a thousand clinical studies looking at using stem cells to treat age-related conditions such as cardiovascular disease.

However, stem cells come with their own expiration date, which usually coincides with the age that most people start experiencing serious health problems. Stem cells harvested from bone marrow at a younger age can potentially provide a therapeutic resource in the future.

“We believe strongly that by having access to your own best possible selves, you’re going to be well positioned to lead healthier, longer lives,” he tells Singularity Hub.

“There’s a compelling argument to be made that if you started to maintain the bone marrow population, the amount of nuclear cells in your bone marrow, and to re-up them so that they aren’t declining with age, it stands to reason that you could absolutely mitigate things like cardiovascular disease and stroke and Alzheimer’s,” he adds.

Clausnitzer notes that the stored stem cells can be used today in developing therapies to treat chronic conditions such as osteoarthritis. However, the more exciting prospect—and the reason he put his own 38-year-old stem cells on ice—is that he believes future stem cell therapies can help stave off the ravages of age-related disease.

“I can start reintroducing them not to treat age-related disease but to treat the decline in the stem-cell niche itself, so that I don’t ever get an age-related disease,” he says. “I don’t think that it equates to immortality, but it certainly is a step in that direction.”

Indecisive on Immortality
The societal implications of a longer-living human species are a guessing game at this point. We do know that by mid-century, the global population of those aged 65 and older will reach 1.6 billion, while those older than 80 will hit nearly 450 million, according to the National Academies of Science. If many of those people could enjoy healthy lives in their twilight years, an enormous medical cost could be avoided.

Faragher is certainly working toward a future where human health is ubiquitous. Human immortality is another question entirely.

“The longer lifespans become, the more heavily we may need to control birth rates and thus we may have fewer new minds. This could have a heavy ‘opportunity cost’ in terms of progress,” he says.

And does anyone truly want to live forever?

“There have been happy moments in my life but I have also suffered some traumatic disappointments. No [drug] will wash those experiences out of me,” Faragher says. “I no longer view my future with unqualified enthusiasm, and I do not think I am the only middle-aged man to feel that way. I don’t think it is an accident that so many ‘immortalists’ are young.

“They should be careful what they wish for.”

Image Credit: Karim Ortiz / Shutterstock.com Continue reading

Posted in Human Robots

#432311 Everyone Is Talking About AI—But Do ...

In 2017, artificial intelligence attracted $12 billion of VC investment. We are only beginning to discover the usefulness of AI applications. Amazon recently unveiled a brick-and-mortar grocery store that has successfully supplanted cashiers and checkout lines with computer vision, sensors, and deep learning. Between the investment, the press coverage, and the dramatic innovation, “AI” has become a hot buzzword. But does it even exist yet?

At the World Economic Forum Dr. Kai-Fu Lee, a Taiwanese venture capitalist and the founding president of Google China, remarked, “I think it’s tempting for every entrepreneur to package his or her company as an AI company, and it’s tempting for every VC to want to say ‘I’m an AI investor.’” He then observed that some of these AI bubbles could burst by the end of 2018, referring specifically to “the startups that made up a story that isn’t fulfillable, and fooled VCs into investing because they don’t know better.”

However, Dr. Lee firmly believes AI will continue to progress and will take many jobs away from workers. So, what is the difference between legitimate AI, with all of its pros and cons, and a made-up story?

If you parse through just a few stories that are allegedly about AI, you’ll quickly discover significant variation in how people define it, with a blurred line between emulated intelligence and machine learning applications.

I spoke to experts in the field of AI to try to find consensus, but the very question opens up more questions. For instance, when is it important to be accurate to a term’s original definition, and when does that commitment to accuracy amount to the splitting of hairs? It isn’t obvious, and hype is oftentimes the enemy of nuance. Additionally, there is now a vested interest in that hype—$12 billion, to be precise.

This conversation is also relevant because world-renowned thought leaders have been publicly debating the dangers posed by AI. Facebook CEO Mark Zuckerberg suggested that naysayers who attempt to “drum up these doomsday scenarios” are being negative and irresponsible. On Twitter, business magnate and OpenAI co-founder Elon Musk countered that Zuckerberg’s understanding of the subject is limited. In February, Elon Musk engaged again in a similar exchange with Harvard professor Steven Pinker. Musk tweeted that Pinker doesn’t understand the difference between functional/narrow AI and general AI.

Given the fears surrounding this technology, it’s important for the public to clearly understand the distinctions between different levels of AI so that they can realistically assess the potential threats and benefits.

As Smart As a Human?
Erik Cambria, an expert in the field of natural language processing, told me, “Nobody is doing AI today and everybody is saying that they do AI because it’s a cool and sexy buzzword. It was the same with ‘big data’ a few years ago.”

Cambria mentioned that AI, as a term, originally referenced the emulation of human intelligence. “And there is nothing today that is even barely as intelligent as the most stupid human being on Earth. So, in a strict sense, no one is doing AI yet, for the simple fact that we don’t know how the human brain works,” he said.

He added that the term “AI” is often used in reference to powerful tools for data classification. These tools are impressive, but they’re on a totally different spectrum than human cognition. Additionally, Cambria has noticed people claiming that neural networks are part of the new wave of AI. This is bizarre to him because that technology already existed fifty years ago.

However, technologists no longer need to perform the feature extraction by themselves. They also have access to greater computing power. All of these advancements are welcomed, but it is perhaps dishonest to suggest that machines have emulated the intricacies of our cognitive processes.

“Companies are just looking at tricks to create a behavior that looks like intelligence but that is not real intelligence, it’s just a mirror of intelligence. These are expert systems that are maybe very good in a specific domain, but very stupid in other domains,” he said.

This mimicry of intelligence has inspired the public imagination. Domain-specific systems have delivered value in a wide range of industries. But those benefits have not lifted the cloud of confusion.

Assisted, Augmented, or Autonomous
When it comes to matters of scientific integrity, the issue of accurate definitions isn’t a peripheral matter. In a 1974 commencement address at the California Institute of Technology, Richard Feynman famously said, “The first principle is that you must not fool yourself—and you are the easiest person to fool.” In that same speech, Feynman also said, “You should not fool the layman when you’re talking as a scientist.” He opined that scientists should bend over backwards to show how they could be wrong. “If you’re representing yourself as a scientist, then you should explain to the layman what you’re doing—and if they don’t want to support you under those circumstances, then that’s their decision.”

In the case of AI, this might mean that professional scientists have an obligation to clearly state that they are developing extremely powerful, controversial, profitable, and even dangerous tools, which do not constitute intelligence in any familiar or comprehensive sense.

The term “AI” may have become overhyped and confused, but there are already some efforts underway to provide clarity. A recent PwC report drew a distinction between “assisted intelligence,” “augmented intelligence,” and “autonomous intelligence.” Assisted intelligence is demonstrated by the GPS navigation programs prevalent in cars today. Augmented intelligence “enables people and organizations to do things they couldn’t otherwise do.” And autonomous intelligence “establishes machines that act on their own,” such as autonomous vehicles.

Roman Yampolskiy is an AI safety researcher who wrote the book “Artificial Superintelligence: A Futuristic Approach.” I asked him whether the broad and differing meanings might present difficulties for legislators attempting to regulate AI.

Yampolskiy explained, “Intelligence (artificial or natural) comes on a continuum and so do potential problems with such technology. We typically refer to AI which one day will have the full spectrum of human capabilities as artificial general intelligence (AGI) to avoid some confusion. Beyond that point it becomes superintelligence. What we have today and what is frequently used in business is narrow AI. Regulating anything is hard, technology is no exception. The problem is not with terminology but with complexity of such systems even at the current level.”

When asked if people should fear AI systems, Dr. Yampolskiy commented, “Since capability comes on a continuum, so do problems associated with each level of capability.” He mentioned that accidents are already reported with AI-enabled products, and as the technology advances further, the impact could spread beyond privacy concerns or technological unemployment. These concerns about the real-world effects of AI will likely take precedence over dictionary-minded quibbles. However, the issue is also about honesty versus deception.

Is This Buzzword All Buzzed Out?
Finally, I directed my questions towards a company that is actively marketing an “AI Virtual Assistant.” Carl Landers, the CMO at Conversica, acknowledged that there are a multitude of explanations for what AI is and isn’t.

He said, “My definition of AI is technology innovation that helps solve a business problem. I’m really not interested in talking about the theoretical ‘can we get machines to think like humans?’ It’s a nice conversation, but I’m trying to solve a practical business problem.”

I asked him if AI is a buzzword that inspires publicity and attracts clients. According to Landers, this was certainly true three years ago, but those effects have already started to wane. Many companies now claim to have AI in their products, so it’s less of a differentiator. However, there is still a specific intention behind the word. Landers hopes to convey that previously impossible things are now possible. “There’s something new here that you haven’t seen before, that you haven’t heard of before,” he said.

According to Brian Decker, founder of Encom Lab, machine learning algorithms only work to satisfy their preexisting programming, not out of an interior drive for better understanding. Therefore, he views AI as an entirely semantic argument.

Decker stated, “A marketing exec will claim a photodiode controlled porch light has AI because it ‘knows when it is dark outside,’ while a good hardware engineer will point out that not one bit in a register in the entire history of computing has ever changed unless directed to do so according to the logic of preexisting programming.”

Although it’s important for everyone to be on the same page regarding specifics and underlying meaning, AI-powered products are already powering past these debates by creating immediate value for humans. And ultimately, humans care more about value than they do about semantic distinctions. In an interview with Quartz, Kai-Fu Lee revealed that algorithmic trading systems have already given him an 8X return over his private banking investments. “I don’t trade with humans anymore,” he said.

Image Credit: vrender / Shutterstock.com Continue reading

Posted in Human Robots

#432051 What Roboticists Are Learning From Early ...

You might not have heard of Hanson Robotics, but if you’re reading this, you’ve probably seen their work. They were the company behind Sophia, the lifelike humanoid avatar that’s made dozens of high-profile media appearances. Before that, they were the company behind that strange-looking robot that seemed a bit like Asimo with Albert Einstein’s head—or maybe you saw BINA48, who was interviewed for the New York Times in 2010 and featured in Jon Ronson’s books. For the sci-fi aficionados amongst you, they even made a replica of legendary author Philip K. Dick, best remembered for having books with titles like Do Androids Dream of Electric Sheep? turned into films with titles like Blade Runner.

Hanson Robotics, in other words, with their proprietary brand of life-like humanoid robots, have been playing the same game for a while. Sometimes it can be a frustrating game to watch. Anyone who gives the robot the slightest bit of thought will realize that this is essentially a chat-bot, with all the limitations this implies. Indeed, even in that New York Times interview with BINA48, author Amy Harmon describes it as a frustrating experience—with “rare (but invariably thrilling) moments of coherence.” This sensation will be familiar to anyone who’s conversed with a chatbot that has a few clever responses.

The glossy surface belies the lack of real intelligence underneath; it seems, at first glance, like a much more advanced machine than it is. Peeling back that surface layer—at least for a Hanson robot—means you’re peeling back Frubber. This proprietary substance—short for “Flesh Rubber,” which is slightly nightmarish—is surprisingly complicated. Up to thirty motors are required just to control the face; they manipulate liquid cells in order to make the skin soft, malleable, and capable of a range of different emotional expressions.

A quick combinatorial glance at the 30+ motors suggests that there are millions of possible combinations; researchers identify 62 that they consider “human-like” in Sophia, although not everyone agrees with this assessment. Arguably, the technical expertise that went into reconstructing the range of human facial expressions far exceeds the more simplistic chat engine the robots use, although it’s the second one that allows it to inflate the punters’ expectations with a few pre-programmed questions in an interview.

Hanson Robotics’ belief is that, ultimately, a lot of how humans will eventually relate to robots is going to depend on their faces and voices, as well as on what they’re saying. “The perception of identity is so intimately bound up with the perception of the human form,” says David Hanson, company founder.

Yet anyone attempting to design a robot that won’t terrify people has to contend with the uncanny valley—that strange blend of concern and revulsion people react with when things appear to be creepily human. Between cartoonish humanoids and genuine humans lies what has often been a no-go zone in robotic aesthetics.

The uncanny valley concept originated with roboticist Masahiro Mori, who argued that roboticists should avoid trying to replicate humans exactly. Since anything that wasn’t perfect, but merely very good, would elicit an eerie feeling in humans, shirking the challenge entirely was the only way to avoid the uncanny valley. It’s probably a task made more difficult by endless streams of articles about AI taking over the world that inexplicably conflate AI with killer humanoid Terminators—which aren’t particularly likely to exist (although maybe it’s best not to push robots around too much).

The idea behind this realm of psychological horror is fairly simple, cognitively speaking.

We know how to categorize things that are unambiguously human or non-human. This is true even if they’re designed to interact with us. Consider the popularity of Aibo, Jibo, or even some robots that don’t try to resemble humans. Something that resembles a human, but isn’t quite right, is bound to evoke a fear response in the same way slightly distorted music or slightly rearranged furniture in your home will. The creature simply doesn’t fit.

You may well reject the idea of the uncanny valley entirely. David Hanson, naturally, is not a fan. In the paper Upending the Uncanny Valley, he argues that great art forms have often resembled humans, but the ultimate goal for humanoid roboticists is probably to create robots we can relate to as something closer to humans than works of art.

Meanwhile, Hanson and other scientists produce competing experiments to either demonstrate that the uncanny valley is overhyped, or to confirm it exists and probe its edges.

The classic experiment involves gradually morphing a cartoon face into a human face, via some robotic-seeming intermediaries—yet it’s in movement that the real horror of the almost-human often lies. Hanson has argued that incorporating cartoonish features may help—and, sometimes, that the uncanny valley is a generational thing which will melt away when new generations grow used to the quirks of robots. Although Hanson might dispute the severity of this effect, it’s clearly what he’s trying to avoid with each new iteration.

Hiroshi Ishiguro is the latest of the roboticists to have dived headlong into the valley.

Building on the work of pioneers like Hanson, those who study human-robot interaction are pushing at the boundaries of robotics—but also of social science. It’s usually difficult to simulate what you don’t understand, and there’s still an awful lot we don’t understand about how we interpret the constant streams of non-verbal information that flow when you interact with people in the flesh.

Ishiguro took this imitation of human forms to extreme levels. Not only did he monitor and log the physical movements people made on videotapes, but some of his robots are based on replicas of people; the Repliee series began with a ‘replicant’ of his daughter. This involved making a rubber replica—a silicone cast—of her entire body. Future experiments were focused on creating Geminoid, a replica of Ishiguro himself.

As Ishiguro aged, he realized that it would be more effective to resemble his replica through cosmetic surgery rather than by continually creating new casts of his face, each with more lines than the last. “I decided not to get old anymore,” Ishiguro said.

We love to throw around abstract concepts and ideas: humans being replaced by machines, cared for by machines, getting intimate with machines, or even merging themselves with machines. You can take an idea like that, hold it in your hand, and examine it—dispassionately, if not without interest. But there’s a gulf between thinking about it and living in a world where human-robot interaction is not a field of academic research, but a day-to-day reality.

As the scientists studying human-robot interaction develop their robots, their replicas, and their experiments, they are making some of the first forays into that world. We might all be living there someday. Understanding ourselves—decrypting the origins of empathy and love—may be the greatest challenge to face. That is, if you want to avoid the valley.

Image Credit: Anton Gvozdikov / Shutterstock.com Continue reading

Posted in Human Robots

#432027 We Read This 800-Page Report on the ...

The longevity field is bustling but still fragmented, and the “silver tsunami” is coming.

That is the takeaway of The Science of Longevity, the behemoth first volume of a four-part series offering a bird’s-eye view of the longevity industry in 2017. The report, a joint production of the Biogerontology Research Foundation, Deep Knowledge Life Science, Aging Analytics Agency, and Longevity.International, synthesizes the growing array of academic and industry ventures related to aging, healthspan, and everything in between.

This is huge, not only in scale but also in ambition. The report, totally worth a read here, will be followed by four additional volumes in 2018, covering topics ranging from the business side of longevity ventures to financial systems to potential tensions between life extension and religion.

And that’s just the first step. The team hopes to publish updated versions of the report annually, giving scientists, investors, and regulatory agencies an easy way to keep their finger on the longevity pulse.

“In 2018, ‘aging’ remains an unnamed adversary in an undeclared war. For all intents and purposes it is mere abstraction in the eyes of regulatory authorities worldwide,” the authors write.

That needs to change.

People often arrive at the field of aging from disparate areas with wildly diverse opinions and strengths. The report compiles these individual efforts at cracking aging into a systematic resource—a “periodic table” for longevity that clearly lays out emerging trends and promising interventions.

The ultimate goal? A global framework serving as a road map to guide the burgeoning industry. With such a framework in hand, academics and industry alike are finally poised to petition the kind of large-scale investments and regulatory changes needed to tackle aging with a unified front.

Infographic depicting many of the key research hubs and non-profits within the field of geroscience.
Image Credit: Longevity.International
The Aging Globe
The global population is rapidly aging. And our medical and social systems aren’t ready to handle this oncoming “silver tsunami.”

Take the medical field. Many age-related diseases such as Alzheimer’s lack effective treatment options. Others, including high blood pressure, stroke, lung or heart problems, require continuous medication and monitoring, placing enormous strain on medical resources.

What’s more, because disease risk rises exponentially with age, medical care for the elderly becomes a game of whack-a-mole: curing any individual disease such as cancer only increases healthy lifespan by two to three years before another one hits.

That’s why in recent years there’s been increasing support for turning the focus to the root of the problem: aging. Rather than tackling individual diseases, geroscience aims to add healthy years to our lifespan—extending “healthspan,” so to speak.

Despite this relative consensus, the field still faces a roadblock. The US FDA does not yet recognize aging as a bona fide disease. Without such a designation, scientists are banned from testing potential interventions for aging in clinical trials (that said, many have used alternate measures such as age-related biomarkers or Alzheimer’s symptoms as a proxy).

Luckily, the FDA’s stance is set to change. The promising anti-aging drug metformin, for example, is already in clinical trials, examining its effect on a variety of age-related symptoms and diseases. This report, and others to follow, may help push progress along.

“It is critical for investors, policymakers, scientists, NGOs, and influential entities to prioritize the amelioration of the geriatric world scenario and recognize aging as a critical matter of global economic security,” the authors say.

Biomedical Gerontology
The causes of aging are complex, stubborn, and not all clear.

But the report lays out two main streams of intervention with already promising results.

The first is to understand the root causes of aging and stop them before damage accumulates. It’s like meddling with cogs and other inner workings of a clock to slow it down, the authors say.

The report lays out several treatments to keep an eye on.

Geroprotective drugs is a big one. Often repurposed from drugs already on the market, these traditional small molecule drugs target a wide variety of metabolic pathways that play a role in aging. Think anti-oxidants, anti-inflammatory, and drugs that mimic caloric restriction, a proven way to extend healthspan in animal models.

More exciting are the emerging technologies. One is nanotechnology. Nanoparticles of carbon, “bucky-balls,” for example, have already been shown to fight viral infections and dangerous ion particles, as well as stimulate the immune system and extend lifespan in mice (though others question the validity of the results).

Blood is another promising, if surprising, fountain of youth: recent studies found that molecules in the blood of the young rejuvenate the heart, brain, and muscles of aged rodents, though many of these findings have yet to be replicated.

Rejuvenation Biotechnology
The second approach is repair and maintenance.

Rather than meddling with inner clockwork, here we force back the hands of a clock to set it back. The main example? Stem cell therapy.

This type of approach would especially benefit the brain, which harbors small, scattered numbers of stem cells that deplete with age. For neurodegenerative diseases like Alzheimer’s, in which neurons progressively die off, stem cell therapy could in theory replace those lost cells and mend those broken circuits.

Once a blue-sky idea, the discovery of induced pluripotent stem cells (iPSCs), where scientists can turn skin and other mature cells back into a stem-like state, hugely propelled the field into near reality. But to date, stem cells haven’t been widely adopted in clinics.

It’s “a toolkit of highly innovative, highly invasive technologies with clinical trials still a great many years off,” the authors say.

But there is a silver lining. The boom in 3D tissue printing offers an alternative approach to stem cells in replacing aging organs. Recent investment from the Methuselah Foundation and other institutions suggests interest remains high despite still being a ways from mainstream use.

A Disruptive Future
“We are finally beginning to see an industry emerge from mankind’s attempts to make sense of the biological chaos,” the authors conclude.

Looking through the trends, they identified several technologies rapidly gaining steam.

One is artificial intelligence, which is already used to bolster drug discovery. Machine learning may also help identify new longevity genes or bring personalized medicine to the clinic based on a patient’s records or biomarkers.

Another is senolytics, a class of drugs that kill off “zombie cells.” Over 10 prospective candidates are already in the pipeline, with some expected to enter the market in less than a decade, the authors say.

Finally, there’s the big gun—gene therapy. The treatment, unlike others mentioned, can directly target the root of any pathology. With a snip (or a swap), genetic tools can turn off damaging genes or switch on ones that promote a youthful profile. It is the most preventative technology at our disposal.

There have already been some success stories in animal models. Using gene therapy, rodents given a boost in telomerase activity, which lengthens the protective caps of DNA strands, live healthier for longer.

“Although it is the prospect farthest from widespread implementation, it may ultimately prove the most influential,” the authors say.

Ultimately, can we stop the silver tsunami before it strikes?

Perhaps not, the authors say. But we do have defenses: the technologies outlined in the report, though still immature, could one day stop the oncoming tidal wave in its tracks.

Now we just have to bring them out of the lab and into the real world. To push the transition along, the team launched Longevity.International, an online meeting ground that unites various stakeholders in the industry.

By providing scientists, entrepreneurs, investors, and policy-makers a platform for learning and discussion, the authors say, we may finally generate enough drive to implement our defenses against aging. The war has begun.

Read the report in full here, and watch out for others coming soon here. The second part of the report profiles 650 (!!!) longevity-focused research hubs, non-profits, scientists, conferences, and literature. It’s an enormously helpful resource—totally worth keeping it in your back pocket for future reference.

Image Credit: Worraket / Shutterstock.com Continue reading

Posted in Human Robots

#432021 Unleashing Some of the Most Ambitious ...

At Singularity University, we are unleashing a generation of women who are smashing through barriers and starting some of the most ambitious technology companies on the planet.

Singularity University was founded in 2008 to empower leaders to use exponential technologies to solve our world’s biggest challenges. Our flagship program, the Global Solutions Program, has historically brought 80 entrepreneurs from around the world to Silicon Valley for 10 weeks to learn about exponential technologies and create moonshot startups that improve the lives of a billion people within a decade.

After nearly 10 years of running this program, we can say that about 70 percent of our successful startups have been founded or co-founded by female entrepreneurs (see below for inspiring examples of their work). This is in sharp contrast to the typical 10–20 percent of venture-backed tech companies that have a female founder, as reported by TechCrunch.

How are we so dramatically changing the game? While 100 percent of the credit goes to these courageous women, as both an alumna of the Global Solutions Program and our current vice chair of Global Grand Challenges, I want to share my reflections on what has worked.

At the most basic level, it is essential to deeply believe in the inherent worth, intellectual genius, and profound entrepreneurial caliber of women. While this may seem obvious, this is not the way our world currently thinks—we live in a world that sees women’s ideas, contributions, work, and existence as inherently less valuable than men’s.

For example, a 2017 Harvard Business Review article noted that even when women engage in the same behaviors and work as men, their work is considered less valuable simply because a woman did the job. An additional 2017 Harvard Business Review article showed that venture capitalists are significantly less likely to invest in female entrepreneurs and are more likely to ask men questions about the potential success of their companies while grilling women about the potential downfalls of their companies.

This doubt and lack of recognition of the genius and caliber of women is also why women are still paid less than men for completing identical work. Further, it’s why women’s work often gets buried in “number two” support roles of men in leadership roles and why women are expected to take on second shifts at home managing tedious household chores in addition to their careers. I would also argue these views as well as the rampant sexual harassment, assault, and violence against women that exists today stems from stubborn, historical, patriarchal views of women as living for the benefit of men, rather than for their own sovereignty and inherent value.

As with any other business, Singularity University has not been immune to these biases but is resolutely focused on helping women achieve intellectual genius and global entrepreneurial caliber by harnessing powerful exponential technologies.

We create an environment where women can physically and intellectually thrive free of harassment to reach their full potential, and we are building a broader ecosystem of alumni and partners around the world who not only support our female entrepreneurs throughout their entrepreneurial journeys, but who are also sparking and leading systemic change in their own countries and communities.

Respecting the Intellectual Genius and Entrepreneurial Caliber of Women
The entrepreneurial legends of our time—Steve Jobs, Elon Musk, Mark Zuckerberg, Bill Gates, Jeff Bezos, Larry Page, Sergey Brin—are men who have all built their empires using exponential technologies. Exponential technologies helped these men succeed faster and with greater impact due to Moore’s Law and the Law of Accelerating Returns which states that any digital technology (such as computing, software, artificial intelligence, robotics, quantum computing, biotechnology, nanotechnology, etc.) will become more sophisticated while dramatically falling in price, enabling rapid scaling.

Knowing this, an entrepreneur can plot her way to an ambitious global solution over time, releasing new applications just as the technology and market are ready. Furthermore, these rapidly advancing technologies often converge to create new tools and opportunities for innovators to come up with novel solutions to challenges that were previously impossible to solve in the past.

For various reasons, women have not pursued exponential technologies as aggressively as men (or were prevented or discouraged from doing so).

While more women are founding firms at a higher rate than ever in wealthy countries like the United States, the majority are small businesses in linear industries that have been around for hundreds of years, such as social assistance, health, education, administrative, or consulting services. In lower-income countries, international aid agencies and nonprofits often encourage women to pursue careers in traditional handicrafts, micro-enterprise, and micro-finance. While these jobs have historically helped women escape poverty and gain financial independence, they have done little to help women realize the enormous power, influence, wealth, and ability to transform the world for the better that comes from building companies, nonprofits, and solutions grounded in exponential technologies.

We need women to be working with exponential technologies today in order to be powerful leaders in the future.

Participants who enroll in our Global Solutions Program spend the first few weeks of the program learning about exponential technologies from the world’s experts and the final weeks launching new companies or nonprofits in their area of interest. We require that women (as well as men) utilize exponential technologies as a condition of the program.

In this sense, at Singularity University women start their endeavors with all of us believing and behaving in a way that assumes they can achieve global impact at the level of our world’s most legendary entrepreneurs.

Creating an Environment Where Woman Can Thrive
While challenging women to embrace exponential technologies is essential, it is also important to create an environment where women can thrive. In particular, this means ensuring women feel at home on our campus by ensuring gender diversity, aggressively addressing sexual harassment, and flipping the traditional culture from one that penalizes women, to one that values and supports them.

While women were initially only a small minority of our Global Solutions Program, in 2014, we achieved around 50% female attendance—a statistic that has since held over the years.

This is not due to a quota—every year we turn away extremely qualified women from our program (and are working on reformulating the program to allow more people to participate in the future.) While part of our recruiting success is due to the efforts of our marketing team, we also benefited from the efforts of some of our early female founders, staff, faculty, and alumnae including Susan Fonseca, Emeline Paat-Dahlstrom, Kathryn Myronuk, Lajuanda Asemota, Chiara Giovenzana, and Barbara Silva Tronseca.

As early champions of Singularity University these women not only launched diversity initiatives and personally reached out to women, but were crucial role models holding leadership roles in our community. In addition, Fonseca and Silva also both created multiple organizations and initiatives outside of (or in conjunction with) the university that produced additional pipelines of female candidates. In particular, Fonseca founded Women@TheFrontier as well as other organizations focusing on women, technology and innovation, and Silva founded BestInnovation (a woman’s accelerator in Latin America), as well as led Singularity University’s Chilean Chapter and founded the first SingularityU Summit in Latin America.

These women’s efforts in globally scaling Singularity University have been critical in ensuring woman around the world now see Singularity University as a place where they can lead and shape the future.

Also, thanks to Google (Alphabet) and many of our alumni and partners, we were able to provide full scholarships to any woman (or man) to attend our program regardless of their economic status. Google committed significant funding for full scholarships while our partners around the world also hosted numerous Global Impact Competitions, where entrepreneurs pitched their solutions to their local communities with the winners earning a full scholarship funded by our partners to attend the Global Solution Program as their prize.

Google and our partners’ support helped individuals attend our program and created a wider buzz around exponential technology and social change around the world in local communities. It led to the founding of 110 SU chapters in 55 countries.

Another vital aspect of our work in supporting women has been trying to create a harassment-free environment. Throughout the Silicon Valley, more than 60% of women convey that while they are trying to build their companies or get their work done, they are also dealing with physical and sexual harassment while being demeaned and excluded in other ways in the workplace. We have taken actions to educate and train our staff on how to deal with situations should they occur. All staff receives training on harassment when they join Singularity University, and all Global Solutions Program participants attend mandatory trainings on sexual harassment when they first arrive on campus. We also have male and female wellness counselors available that can offer support to both individuals and teams of entrepreneurs throughout the entire program.

While at a minimum our campus must be physically safe for women, we also strive to create a culture that values women and supports them in the additional challenges and expectations they face. For example, one of our 2016 female participants, Van Duesterberg, was pregnant during the program and said that instead of having people doubt her commitment to her startup or make her prove she could handle having a child and running a start-up at the same time, people went out of their way to help her.

“I was the epitome of a person not supposed to be doing a startup,” she said. “I was pregnant and would need to take care of my child. But Singularity University was supportive and encouraging. They made me feel super-included and that it was possible to do both. I continue to come back to campus even though the program is over because the network welcomes me and supports me rather than shuts me out because of my physical limitations. Rather than making me feel I had to prove myself, everyone just understood me and supported me, whether it was bringing me healthy food or recommending funders.”

Another strength that we have in supporting women is that after the Global Solutions Program, entrepreneurs have access to a much larger ecosystem.

Many entrepreneurs partake in SU Ventures, which can provide further support to startups as they develop, and we now have a larger community of over 200,000 people in almost every country. These members have often attended other Singularity University programs, events and are committed to our vision of the future. These women and men consist of business executives, Fortune 500 companies, investors, nonprofit and government leaders, technologists, members of the media, and other movers and shakers in the world. They have made introductions for our founders, collaborated with them on business ventures, invested in them and showcased their work at high profile events around the world.

Building for the Future
While our Global Solutions Program is making great strides in supporting female entrepreneurs, there is always more work to do. We are now focused on achieving the same degree of female participation across all of our programs and actively working to recruit and feature more female faculty and speakers on stage. As our community grows and scales around the world, we are also intent at how to best uphold our values and policies around sexual harassment across diverse locations and cultures. And like all businesses everywhere, we are focused on recruiting more women to serve at senior leadership levels within SU. As we make our way forward, we hope that you will join us in boldly leading this change and recognizing the genius and power of female entrepreneurs.

Meet Some of Our Female Moonshots
While we have many remarkable female entrepreneurs in the Singularity University community, the list below features a few of the women who have founded or co-founded companies at the Global Solutions Program that have launched new industries and are on their way to changing the way our world works for millions if not billions of people.

Jessica Scorpio co-founded Getaround in 2009. Getaround was one of the first car-sharing service platforms allowing anyone to rent out their car using a smartphone app. GetAround was a revolutionary idea in 2009, not only because smartphones and apps were still in their infancy, but because it was unthinkable that a technology startup could disrupt the major entrenched car, transport, and logistics companies. Scorpio’s early insights and pioneering entrepreneurial work brought to life new ways that humans relate to car sharing and the future self-driving car industry. Scorpio and Getaround have won numerous awards, and Getaround now serves over 200,000 members.

Paola Santana co-founded Matternet in 2011, which pioneered the commercial drone transport industry. In 2011, only military, hobbyists or the film industry used drones. Matternet demonstrated that drones could be used for commercial transport in short point-to-point deliveries for high-value goods laying the groundwork for drone transport around the world as well as some of the early thinking behind the future flying car industry. Santana was also instrumental in shaping regulations for the use of commercial drones around the world, making the industry possible.

Sara Naseri co-founded Qurasense in 2014, a life sciences start-up that analyzes women’s health through menstrual blood allowing women to track their health every month. Naseri is shifting our understanding of women’s menstrual blood as a waste product and something “not to be talked about,” to a rich, non-invasive, abundant source of information about women’s health.

Abi Ramanan co-founded ImpactVision in 2015, a software company that rapidly analyzes the quality and characteristics of food through hyperspectral images. Her long-term vision is to digitize food supply chains to reduce waste and fraud, given that one-third of all food is currently wasted before it reaches our plates. Ramanan is also helping the world understand that hyperspectral technology can be used in many industries to help us “see the unseen” and augment our ability to sense and understand what is happening around us in a much more sophisticated way.

Anita Schjøll Brede and Maria Ritola co-founded Iris AI in 2015, an artificial intelligence company that is building an AI research assistant that drastically improves the efficiency of R&D research and breaks down silos between different industries. Their long-term vision is for Iris AI to become smart enough that she will become a scientist herself. Fast Company named Iris AI one of the 10 most innovative artificial intelligence companies for 2017.

Hla Hla Win co-founded 360ed in 2016, a startup that conducts teacher training and student education through virtual reality and augmented reality in Myanmar. They have already connected teachers from 128 private schools in Myanmar with schools teaching 21st-century skills in Silicon Valley and around the world. Their moonshot is to build a platform where any teacher in the world can share best practices in teachers’ training. As they succeed, millions of children in some of the poorest parts of the world will have access to a 21st-century education.

Min FitzGerald and Van Duesterberg cofounded Nutrigene in 2017, a startup that ships freshly formulated, tailor-made supplement elixirs directly to consumers. Their long-term vision is to help people optimize their health using actionable data insights, so people can take a guided, tailored approaching to thriving into longevity.

Anna Skaya co-founded Basepaws in 2016, which created the first genetic test for cats and is building a community of citizen scientist pet owners. They are creating personalized pet products such as supplements, therapeutics, treats, and toys while also developing a database of genetic data for future research that will help both humans and pets over the long term.

Olivia Ramos co-founded Deep Blocks in 2016, a startup using artificial intelligence to integrate and streamline the processes of architecture, pre-construction, and real estate. As digital technologies, artificial intelligence, and robotics advance, it no longer makes sense for these industries to exist separately. Ramos recognized the tremendous value and efficiency that it is now possible to unlock with exponential technologies and creating an integrated industry in the future.

Please also visit our website to learn more about other female entrepreneurs, staff and faculty who are pioneering the future through exponential technologies. Continue reading

Posted in Human Robots